共 50 条
- [21] Menopausal vulvovaginal atrophy: comparative effectiveness of vaginal therapies MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1388 - 1388
- [22] Local Estrogen or Systemic Opsemifene for Treatment of Vulvovaginal Atrophy and Their Effects on Mammographic Density MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1406 - 1407
- [23] Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2011, 38 (02): : 143 - 145
- [25] Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis SCIENTIFIC REPORTS, 2016, 6
- [26] Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis Scientific Reports, 6
- [27] Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (05): : 877 - 882
- [28] SAFETY AND EFFICACY OF OSPEMIFENE, A SELECTIVE ESTROGEN RECEPTOR MODULATOR, FOR TREATEMENT OF POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 165 - 165
- [29] One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (11): : 1197 - 1203
- [30] Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2009, 1 : 105 - 111